| Literature DB >> 30753446 |
Stéphanie Bedhomme1, Dolors Amorós-Moya2, Luz M Valero3, Nùria Bonifaci4, Miquel-Àngel Pujana4, Ignacio G Bravo5.
Abstract
Genes acquired by horizontal gene transfer (HGT) may provide the recipient organism with potentially new functions, but proper expression level and integration of the transferred genes in the novel environment are not granted. Notably, transferred genes can differ from the receiving genome in codon usage preferences, leading to impaired translation and reduced functionality. Here, we characterize the genomic and proteomic changes undergone during experimental evolution of Escherichia coli after HGT of three synonymous versions, presenting very different codon usage preference, of an antibiotic resistance gene. The experimental evolution was conducted with and without the corresponding antibiotic and the mutational patterns and proteomic profiles after 1,000 generations largely depend on the experimental growth conditions (e.g., mutations in antibiotic off-target genes), and on the synonymous gene version transferred (e.g., mutations in genes responsive to translational stress). The transfer of an exogenous gene extensively modifies the whole proteome, and these proteomic changes are different for the different version of the transferred gene. Additionally, we identified conspicuous changes in global regulators and in intermediate metabolism, confirmed the evolutionary ratchet generated by mutations in DNA repair genes and highlighted the plasticity of bacterial genomes accumulating large and occasionally transient duplications. Our results support a central role of HGT in fuelling evolution as a powerful mechanism promoting rapid, often dramatic genotypic and phenotypic changes. The profound reshaping of the pre-existing geno/phenotype allows the recipient bacteria to explore new ways of functioning, far beyond the mere acquisition of a novel function.Entities:
Keywords: antibiotic resistance; codon usage preferences; compensatory evolution; experimental evolution; horizontal gene transfer
Mesh:
Substances:
Year: 2019 PMID: 30753446 PMCID: PMC6427688 DOI: 10.1093/gbe/evz031
Source DB: PubMed Journal: Genome Biol Evol ISSN: 1759-6653 Impact factor: 3.416
Fig. 3.—Functional enrichment analysis for genes present in duplicated genomic stretches. Gene functions were searched from annotations in the KEGG and in the GO repositories. Gray lines display the overrepresentation of genes in a given functional category in the corresponding duplicated genomic stretches of a bacterial population. A line linking a category to a given population reflects enrichment of this functional category in this population. The sharp split between populations selected in chloramphenicol and in ampicillin is a result of the analysis and has not been enforced.
Fig. 1.—Mutation spectra in evolved populations. Number of events for different mutation types per population, at generations 458 (A, C) and 1,000 (B, D) for wild-type (A, B) and mutator (C, D) populations. In blue, SNP (“S,” synonymous; “NS,” nonsynonymous; and “interg,” intergenic); in green, small insertions and deletions (<30 bp); in pink, insertion sequences; in orange, duplications; and in yellow, deletions. The bar depict the median, boxplots show first and third quartiles, and whiskers span the 95%. P values correspond to Mann–Whitney tests comparing the number of same type mutations in wild-type and mutator populations for a same generation.
List of Genes Mutated in Five or More Populations at Generation 1000
| Mutated gene | Antibiotic | Gene Version | Amino Acid Change or Mutation; Protein Length (p.l.) | Protein Function | |||
|---|---|---|---|---|---|---|---|
| AT | GC | OPT | |||||
| AMP | A392V(3), L571V, F583L(3), A626V, A626T, D672N; p.l.: 891 aa | Fused acetaldehyde-CoA dehydrogenase and iron-dependent alcohol dehydrogenase—inhibited by chloramphenicol | |||||
| CAM | |||||||
| AMP | I55V, R67C, N85D, N85H, V87A, E94G, E86G, D99G(3), N106T, T126A; p.l.: 239 aa | Global regulator. Regulates genes involved in redox metabolism | |||||
| CAM | |||||||
| AMP | IS10 2, ins 1 bp 73(2), A286D, IS1 3049; p.l.: 1,050 aa | Component of a multidrug efflux pump | |||||
| CAM | |||||||
| AMP | W248R, V263V, G292A, E350G(3), Q247R, A354V, L255R, I259S; p.l.: 388 aa | Succinyl CoA synthase beta-subunit | |||||
| CAM | |||||||
| AMP | T46A, insT 534, IS2 42, IS10 124(2), IS2 366, IS150 557; p.l.: 216 aa | Fatty acid biosynthesis regulator | |||||
| CAM | |||||||
| AMP | S103P, H179R, Y286H, G314S, Y391C, N456H; p.l. 702 aa | Guanosine-3′,5′-bis(diphosphate) 3′-pyrophosphohydrolase (both synthesizes and hydrolyzes the alarmone [p]ppGpp) | |||||
| CAM | |||||||
| AMP | Y158H, E323K(2), Y713H; p.l.: 814 aa | Fatty acid degradation, starvation inducible | |||||
| CAM | |||||||
| AMP | S86P, A431V, C472R, Y548D, IS10 1387, del 1bp 829, ins 1 bp 1382, IS10 1387, del 1bp 1492; p.l.: 564 aa | Fructose permease (membrane spanning protein) | |||||
| CAM | |||||||
| AMP | IS10 1870(4), T > C 317; pseudogene length: 2,009 nt | Pseudogene | |||||
| CAM | |||||||
| AMP | putP (D55G[2], I254V, I435F; p.l.: 502 aa), slt (G198D, ins 1 bp 275, ins 1 bp 1223; p.l.: 646 aa) | PutP: Na+/l-proline transporter; Slt: soluble lytic transglycosylase, cleaves murein residues | |||||
| CAM | |||||||
| AMP | Y154C, L157*(2); p.l.: 179 aa | 30S ribosomal subunit protein S7 | |||||
| CAM | |||||||
| AMP | IS10 977(3), IS10 1423(2); p.l.: 616 aa | Methyl-directed mismatch repair protein | |||||
| CAM | |||||||
| AMP | Y53D, del 1 bp 138, IS4 142(2), L204P, A257P, IS10 292, IS10 624 (2); p.l.: 342 aa | Antiactivator (TF) for nucleoside utilization regulon. Controls genes involved in (deoxy)nucleoside uptake and metabolism | |||||
| CAM | |||||||
| AMP | IS10 1552(2), IS10 1999(2), IS10 2463(2); p.l.: 854 aa | Methyl-directed mismatch repair protein | |||||
| CAM | |||||||
| AMP | ClpX: ATPase subunit of ClpXP protease, molecular chaperone; | ||||||
| CAM | |||||||
| AMP | S25P, D89G(2), L61P, ins 8 bp 64(2); p.l.: 115 aa | Unknown function | |||||
| CAM | |||||||
Note.—The first column indicates the result of the nominal logistic regression (see Material and Methods). Shades of blue in the third column reflect whether 0, 1, 2, or 3 of the replicate populations in each gene version × antibiotic combination were mutated. The fourth column gives the position of the mutations within the protein, with either the corresponding amino acid change, the small indel, or the IS insertion event. Numbers in parentheses/brackets indicate the number of bacterial populations in which the indicated mutation was found. The fifth column describes the function of the protein. “p.l.,” protein length.
Significant effect of the interaction “gene version × antibiotic.”
Fig. 2.—Position and size of the duplications, deletions, and new insertion sequences in the 36 evolved genomes sequences.
Fig. 4.—Comparative proteomics and unsupervised clustering of the proteome profiles in bacterial populations. For both analyses, the AT-cat generation zero bacteria served as reference for protein levels. Each horizontal line within a red-to-green gradient reflects the lower-to-higher levels of an individual protein. In the right boxes, enriched functional categories in either the KEGG and in the GO repositories are given for horizontal clusters. (A) Comparison of ancestral populations and evolved populations. Populations have been pooled within gene version × antibiotic of selection combination (bacterial lines carrying the AT-cat gene were not included because of methodological constrains). (B) For bacterial lines carrying the AT-cat gene, comparison of evolved population under ampicillin (Amp) or chloramphenicol (Cam) with ancestral bacteria transformed with plasmids extracted from the evolved populations (labeled as “tr”).
Fig. 5.—Heatmap of the relative quantities of candidate proteins in ancestral and evolved populations. Fold changes are expressed relative to the levels in the AT-cat g0 population, in the gradient blue-white-red. Intense colors indicate fold changes significantly different from 1.